Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hospira, Inc.

http://www.hospira.com

Latest From Hospira, Inc.

Tech Transfer Roundup: Lysogene Elects Option On Gene Therapy Discovered At Weizmann Institute

French biotech brings candidate for Gaucher and Parkinson’s disease in-house under 2020 pact with Weizmann. Cellevolve, Seattle Children’s partner on cell therapies for CNS cancers.

Tech Transfer Round-Up Deals

A Tricky Outlook, But Medtech Has Opportunities To Grow

In Vivo editorial advisory board member and ZS principal Brian Chapman identifies the agenda-topping themes for medtech bosses.

Strategy Growth

A Tricky Outlook, But Medtech Has Opportunities To Grow

In Vivo editorial advisory board member and ZS principal Brian Chapman identifies the agenda-topping themes for medtech bosses.

Medical Device Strategy

Health Care Industry Reacts To War In Ukraine

Many health care businesses have condemned the war in Ukraine while prioritizing the safety of local employees and pledging support and humanitarian aid. They must also consider their own operational issues during and after the conflict.

Ukraine Market Intelligence
See All

Company Information

  • Other Names / Subsidiaries
    • Javelin Pharmaceuticals, Inc.
    • Mayne Pharma Limited
UsernamePublicRestriction

Register